Standout Papers

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized... 2013 2026 2017 2021 415
  1. Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial (2013)
    Jin Li, Shukui Qin et al. Journal of Clinical Oncology

Immediate Impact

2 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Bio-inspired electronics: Soft, biohybrid, and “living” neural interfaces
2025 Standout
3 intermediate papers

Works of Nong Xu being referenced

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
2017
Persistent Delivery of Factor IX in Mice: Gene Therapy for Hemophilia Using Implantable Microcapsules
1999
and 1 more

Author Peers

Author Last Decade Papers Cites
Nong Xu 930 781 431 95 1.6k
Nozomu Fuse 731 778 373 92 1.5k
H Arnholdt 936 627 533 75 2.0k
Zhi Peng 1256 640 414 101 2.0k
Jin Hee Sohn 803 649 575 100 2.0k
Yung‐Jue Bang 1256 1060 399 72 1.9k
Zhehai Wang 1014 831 228 80 1.7k
Federica Bertolini 1154 927 910 119 2.2k
Heung-Moon Chang 1401 888 653 78 2.0k
Autumn J. McRee 1061 559 331 50 1.5k
Yusuke Onozawa 703 882 642 129 1.6k

All Works

Loading papers...

Rankless by CCL
2026